{"id":1237,"date":"2023-01-27T03:04:10","date_gmt":"2023-01-27T03:04:10","guid":{"rendered":"http:\/\/agderma.de\/?page_id=1237"},"modified":"2024-02-02T09:26:26","modified_gmt":"2024-02-02T09:26:26","slug":"que-son-los-disruptores-endocrinos","status":"publish","type":"page","link":"https:\/\/agderma.de\/es\/themen\/was-sind-endokrine-disruptoren\/","title":{"rendered":"\u00bfQu\u00e9 son los alteradores endocrinos?"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1237\" class=\"elementor elementor-1237\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3d478ea e-flex e-con-boxed e-con e-parent\" data-id=\"3d478ea\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3d3f871 elementor-widget elementor-widget-heading\" data-id=\"3d3f871\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Was sind endokrine Disruptoren?<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-2179231 e-flex e-con-boxed e-con e-parent\" data-id=\"2179231\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3c12a81 elementor-widget elementor-widget-text-editor\" data-id=\"3c12a81\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/www.bfr.bund.de\/de\/fragen_und_antworten_zu_endokrinen_disruptoren-50513.html\" target=\"_blank\" rel=\"noopener\">Endokrine Disruptoren<\/a>\u00a0sind industriell hergestellte chemische Substanzen, die Hormone imitieren, indem sie an einen Hormonrezeptor einer Zelle binden, eine dem Hormon \u00e4hnliche Wirkung verursachen oder Rezeptor blockieren. Sie ver\u00e4ndern so die Funktion des endokrinen Systems und stehen in dringendem Verdacht, zu\u00a0<a href=\"http:\/\/a)\thttps:\/\/chemicalsinourlife.echa.europa.eu\/de\/endocrine-disrupters-and-our-health\" data-wplink-url-error=\"true\">gesundheitlichen Sch\u00e4den<\/a>\u00a0zu f\u00fchren:<\/p><ul><li>Abnahme der Fertilit\u00e4t durch eine sinkende Spermienqualit\u00e4t<\/li><li>Fehlbildungen m\u00e4nnlicher und weiblicher Geschlechtsorgane<\/li><li>Stoffwechselerkrankungen (Diabetes mellitus, Adipositas)<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28387320\" target=\"_blank\" rel=\"noopener\">Verhaltensauff\u00e4lligkeiten<\/a>\u00a0wie z. B. Autismus, ADHS<\/li><li>neurologischen Erkrankungen wie z. B. Alzheimer, Parkinson<\/li><li>Autoimmunerkrankungen<\/li><li>fr\u00fcheres Einsetzen der Pubert\u00e4t<\/li><li>Auftreten von Tumoren (Prostata-, Hoden- und Brustkrebs) durch Imitation der Sexualhormone<\/li><li>zudem wird eine\u00a0<a href=\"http:\/\/www.europarl.europa.eu\/RegData\/etudes\/STUD\/2019\/608866\/IPOL_STU(2019)608866_EN.pdf\" target=\"_blank\" rel=\"noopener\">Minderung der Intelligenz<\/a> diskutiert<\/li><\/ul><p>Aktuell werden durch die\u00a0<a href=\"https:\/\/ec.europa.eu\/growth\/content\/call-data-ingredients-potential-endocrine-disrupting-properties-used-cosmetic-products_en\" target=\"_blank\" rel=\"noopener\">Europ\u00e4ische Kommission<\/a>\u00a028 Substanzen und Inhaltsstoffe diskutiert, die m\u00f6glicherweise endokrin aktiv sein k\u00f6nnten. 14 Substanzen davon haben eine hohe Priorit\u00e4t. In einer\u00a0<a href=\"https:\/\/ec.europa.eu\/health\/\/sites\/health\/files\/endocrine_disruptors\/docs\/2016_impact_assessment_study_en.pdf\" target=\"_blank\" rel=\"noopener\">\u00dcbersichtstudie der EU<\/a>\u00a0geh\u00f6ren dazu 6 Substanzen (Benzophenone-3, Kojic acid, 4-methylbenzylidene Camphor, Propylparaben,\u00a0<a href=\"https:\/\/agderma.de\/themen\/triclosan-ein-problematischer-stoff\/\">Triclosan<\/a>\u00a0und Resorcinol), die in kosmetischen Produkten verwendet werden und bisher nicht durch ein bestehendes oder laufendes Verbot abgedeckt werden.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b784c6a elementor-widget elementor-widget-text-editor\" data-id=\"b784c6a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<table><thead><tr><th>INCI name (International Nomenclature of Cosmetic Ingredients)<\/th><th>Chemical name<\/th><\/tr><\/thead><tbody><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.004.575\" target=\"_blank\" rel=\"noopener\">Benzophenone-3<\/a><\/td><td>2-hydroxy-4-methoxybenzophenone<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.007.203\" target=\"_blank\" rel=\"noopener\">Kojic acid<\/a><\/td><td>5-hydroxy-2-hydroxymethyl-4-pyrone<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.048.386\" target=\"_blank\" rel=\"noopener\">4-Methylbenzylidene camphor<\/a><\/td><td>(\u00b1)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.002.098\" target=\"_blank\" rel=\"noopener\">Propylparaben<\/a><\/td><td>Propyl 4-hydroxybenzoate<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.020.167\" target=\"_blank\" rel=\"noopener\">Triclosan<\/a><\/td><td>5-chloro-2-(2,4-dichlorophenoxy)phenol<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.003.260\" target=\"_blank\" rel=\"noopener\">Resorcinol<\/a><\/td><td>1,3-benzenediol<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.025.683\" target=\"_blank\" rel=\"noopener\">Octocrylene<\/a><\/td><td>2-cyano-3,3-diphenyl acrylic acid 2-ethylhexyl ester<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.002.659\" target=\"_blank\" rel=\"noopener\">Triclocarban<\/a><\/td><td>1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.004.439\" target=\"_blank\" rel=\"noopener\">BHT (butylated hydroxytoluene)<\/a><\/td><td>2,6-di-tert-butyl-p-cresol<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.003.943\" target=\"_blank\" rel=\"noopener\">Benzophenone<\/a><\/td><td>Benzophenone<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.003.874\" target=\"_blank\" rel=\"noopener\">Homosalate<\/a><\/td><td>2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester or benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.003.876\" target=\"_blank\" rel=\"noopener\">Benzyl salicylate<\/a><\/td><td>Benzyl salicylate<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.006.524\" target=\"_blank\" rel=\"noopener\">Genistein<\/a><\/td><td>5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone<\/td><\/tr><tr><td><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.006.942\" target=\"_blank\" rel=\"noopener\">Daidzein<\/a><\/td><td>4&#8242;,7-dihydroxyisoflavone or 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one or 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one\u201d<\/td><\/tr><\/tbody><\/table><p>Quelle:\u00a0<a href=\"https:\/\/ec.europa.eu\/newsroom\/growth\/items\/702447\" target=\"_blank\" rel=\"noopener\">European Commission: Call for data on ingredients with potential endocrine-disrupting properties used in cosmetic products<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-65b83a4 elementor-widget elementor-widget-text-editor\" data-id=\"65b83a4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Weiterhin sind als mutma\u00dfliche endokrine Disruptoren aufgef\u00fchrt<\/p><ul><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.002.108\" target=\"_blank\" rel=\"noopener\">Butylparaben<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.042.315\" target=\"_blank\" rel=\"noopener\">Tert-butylhydroxyanisole\/Butylated hydroxyanisole\/BHA<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.157.824\" target=\"_blank\" rel=\"noopener\">Ethylhexyl methoxycinnamate(EHMC)\/Octylmethoxycinnamate (OMC)\/Octinoxate<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.003.943\" target=\"_blank\" rel=\"noopener\">Benzophenone<\/a>-1\/BP-1, Benzophenone-2\/BP-2, Benzophenone-4\/BP-4, Benzophenone-5\/BP-5,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.002.532\" target=\"_blank\" rel=\"noopener\">Methylparaben<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.025.641\" target=\"_blank\" rel=\"noopener\">Cyclopentasiloxane\/decamethylcyclopentasiloxane\/D5<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.025.641\" target=\"_blank\" rel=\"noopener\">Cyclomethicone<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.000.648\" target=\"_blank\" rel=\"noopener\">Salicylic acid<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.001.173\" target=\"_blank\" rel=\"noopener\">Butylphenyl methylpropianol\/BMHCA<\/a>,<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.003.739\" target=\"_blank\" rel=\"noopener\">Triphenyl Phosphate<\/a> und<\/li><li><a href=\"https:\/\/echa.europa.eu\/de\/substance-information\/-\/substanceinfo\/100.052.943\" target=\"_blank\" rel=\"noopener\">Deltamethrin<\/a>.<\/li><\/ul><p>\u00a0<\/p><p>Wann, f\u00fcr welchen Stoff und ob ein Verbot gem\u00e4\u00df der\u00a0<a href=\"https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:de:PDF\" target=\"_blank\" rel=\"noopener\">VO (EG) 1223\/2009 \u00fcber kosmetische Mittel des Europ\u00e4ischen Parlaments<\/a>\u00a0in Kraft tritt, ist aktuell noch unklar.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5361cbc elementor-widget elementor-widget-toggle\" data-id=\"5361cbc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-8741\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"button\" aria-controls=\"elementor-tab-content-8741\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">Literaturverweise und rechtliche Hinweise<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-8741\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"region\" aria-labelledby=\"elementor-tab-title-8741\"><p>\u00a9 Dr. med. Dipl. Biol. Susanne Saha 03\/2021<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Endokrine Disruptoren\u00a0sind industriell hergestellte chemische Substanzen, die Hormone imitieren, indem sie an einen Hormonrezeptor einer Zelle binden, eine dem Hormon \u00e4hnliche Wirkung verursachen oder Rezeptor blockieren. Sie ver\u00e4ndern so die Funktion des endokrinen Systems und stehen in dringendem Verdacht, zu\u00a0gesundheitlichen Sch\u00e4den\u00a0zu f\u00fchren: Abnahme der Fertilit\u00e4t durch eine sinkende Spermienqualit\u00e4t Fehlbildungen m\u00e4nnlicher und weiblicher Geschlechtsorgane Stoffwechselerkrankungen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1142,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1237","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/pages\/1237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/comments?post=1237"}],"version-history":[{"count":7,"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/pages\/1237\/revisions"}],"predecessor-version":[{"id":4940,"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/pages\/1237\/revisions\/4940"}],"up":[{"embeddable":true,"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/pages\/1142"}],"wp:attachment":[{"href":"https:\/\/agderma.de\/es\/wp-json\/wp\/v2\/media?parent=1237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}